Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
暂无分享，去创建一个
O. Griffith | F. Gao | M. Griffith | A. Petti | N. Bartlett | M. Becker-Hapak | P. Soon-Shiong | Matthew Mosior | T. Fehniger | B. Hess | V. Bachanova | A. Cashen | John H. Lee | N. Mehta-Shah | B. Kahl | N. Epperla | Julia A. Wagner | M. Foster | Timothy Schappe | Ethan McClain | Jennifer A. Foltz | Nancy D. Marin | A. Rock | M. Berrien-Elliott | Kristen McDaniels | Chaz Moreno | J. Foltz